Supplementary Table 5.
Comparison of the distribution of MCP1 rs1024611 polymorphic variants between HD patients with isolated anti-HBc positivity and HD patients with HBV resolution.
| Genotype | HD patients with isolated anti-HBc positivity (frequency) | HD patients anti-HBc positive/HBsAg negative/anti-HBs positive HD (frequency) | Odds ratio (95%CI) | Two-tailed P | Ptrend | Pgenotyping | Power (%) |
|---|---|---|---|---|---|---|---|
| All HD patients | |||||||
| n=28 | n=126 | ||||||
| AA | 16 (0.57) | 66 (0.52) | Referent | – | 0.427 | 0.586 | |
| AG | 11 (0.39) | 48 (0.38) | 1.058 (0.417–2.765) | 1.000 | 3.8 | ||
| GG | 1 (0.04) | 12 (0.10) | 2.909 (0.373–132.0) | 0.550 | 2.6 | ||
| AG+GG | 12 (0.43) | 60 (0.48) | 1.212 (0.492–3.052) | 0.807 | 5.4 | ||
| MAF | 13 (0.23) | 72 (0.29) | 1.323 (0.650–2.844) | 0.525 | 10.1 | ||
anti-HBc – antibodies to core antigen of hepatitis B virus; HBV – hepatitis B virus; HD – hemodialysis.